Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Luis Manso Sánchez"'
Autor:
Alberto Carretero-González, Marta Hergueta-Redondo, Sara Sánchez-Redondo, Pilar Ximénez-Embún, Luis Manso Sánchez, Eva Ciruelos Gil, Daniel Castellano, Guillermo de Velasco, Héctor Peinado
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Nearly 40% of the advanced cancer patients will present brain metastases during the course of their disease, with a 2-year life expectancy of less than 10%. Immune system impairment, including the modulation of both STAT3 and PD-L1, is one of the hal
Externí odkaz:
https://doaj.org/article/abc9d2f726114963ae9a80538f61a02d
Autor:
José Alejandro Perez-Fidalgo, Eva Guerra, Yolanda García, María Iglesias, María Hernández-Sosa, Purificación Estevez-García, Luis Manso Sánchez, Ana Santaballa, Ana Oaknin, Andres Redondo, M Jesús Rubio, Antonio González-Martín
Publikováno v:
International Journal of Gynecologic Cancer. :ijgc-2022
ObjectiveTo determine the potential prognostic value of clinical and molecular biomarkers in the survival of patients with platinum-resistant ovarian cancer treated with olaparib and pegylated liposomal doxorubicin.MethodsROLANDO was a single-arm pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dc0560325211448649c255e3bd6ee69
https://doi.org/10.1136/ijgc-2022-004028
https://doi.org/10.1136/ijgc-2022-004028
Autor:
Grupo Español de Investigación en Cáncer de Ovario, Y. García, Alfonso Cortés Salgado, Ana Oaknin, Uriel Bohn Sarmiento, M. J. Rubio, Maria Iglesias, Antonio González-Martín, Andrés Redondo, Ana Santaballa, Luis Manso Sánchez, Jose Alejandro Perez-Fidalgo, Elisa Calvo García
Publikováno v:
Journal of Clinical Oncology. 39:5549-5549
5549 Background: The prognosis for patients with platinum-resistant/refractory ovarian cancer (PROC) is poor, and the aim of treatment is focused primarily on symptom control and maintenance of QoL. The objective of this study was to assess the impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::956072cb6340e13903cacefb58dcfd78
https://doi.org/10.1200/jco.2021.39.15_suppl.5549
https://doi.org/10.1200/jco.2021.39.15_suppl.5549
Autor:
Luis Manso Sánchez, Maria Lomas Garrido, Ana Jaén Morago, Paula Espinosa Olarte, Cristina Pernaut Sánchez, Pedro Sánchez Rovira
Publikováno v:
Future oncology (London, England). 14(7s)
Although advancing age can greatly increase the complexities of treating metastatic breast cancer, chronological age alone is insufficient to determine the type or intensity of treatment. Older patients require an individualized approach that takes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b3863a19f8df97a3d54e7cd57ea9c0
https://pubmed.ncbi.nlm.nih.gov/29611758
https://pubmed.ncbi.nlm.nih.gov/29611758
Publikováno v:
Clinical and Translational Oncology. 6:245-257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::167d13edff82827ae87f0d79ce1e1369
https://doi.org/10.1007/bf02711730
https://doi.org/10.1007/bf02711730